Disease Overview：Atrial flutter（AFL）
Atrial flutter is a common cardiac arrhythmia characterized by rapid, regular atrial depolarizations—typically at 250–350 beats per minute—resulting from a macro-reentrant circuit, most often in the right atrium around the tricuspid valve annulus. Unlike atrial fibrillation, it exhibits organized electrical activity on electrocardiography (ECG), with characteristic “sawtooth” flutter waves. Patients may experience palpitations, dyspnea, fatigue, dizziness, or thromboembolic complications—including stroke—due to stasis-induced left atrial appendage thrombus formation. Diagnosis relies on 12-lead ECG, Holter monitoring, and echocardiography; management includes rate control, anticoagulation, and definitive rhythm restoration via pharmacologic cardioversion or catheter ablation—particularly radiofrequency or cryoablation targeting the cavotricuspid isthmus.
China offers distinct advantages for atrial flutter treatment: its leading cardiovascular centers—such as Fuwai Hospital and Shanghai Ruijin Hospital—employ electrophysiologists with extensive experience in complex ablation procedures, supported by state-of-the-art 3D electroanatomic mapping systems (e.g., CARTO, EnSite) and robotic navigation platforms. Clinical outcomes align with international benchmarks, with >95% acute procedural success and low recurrence rates (<10% at one year). Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising safety or efficacy. As a dedicated medical tourism agency, we facilitate seamless access for international patients—coordinating hospital referrals, verifying physician credentials, providing itemized, transparent pricing, arranging visas and local logistics, and offering multilingual clinical support throughout the care journey.
Atrial flutter: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Atrial Flutter (Cardiology Department)
Non-Surgical / Conservative Management
*Target criteria:* Stable, first-episode or recurrent typical flutter without hemodynamic instability, contraindications to ablation, or low thromboembolic risk (CHADS₂-VASc ≤1).
- •Rate Control Medications (3–6 months initial course):
- Diltiazem IV + oral transition: ¥120–¥200/course → $17–$28
- •Rhythm Control (Pharmacologic):
- Amiodarone (200 mg/day, monitored): ¥90–¥130/month + mandatory LFT/Thyroid US/EKG q3mo → $13–$18 + $45–$65/q3mo
- •Anticoagulation:
- Warfarin + INR monitoring (12 tests/year): ¥60/test + drug → $8 + $12 = $20/month
- •Baseline Workup (per episode):
- TTE (transthoracic echocardiogram): ¥420 → $59 - Blood: PT/INR, renal function, electrolytes, TSH: ¥260 → $36
Surgical / Procedural Intervention
*Eligibility:* Recurrent symptomatic flutter despite ≥2 antiarrhythmics, typical flutter on ECG, no contraindications to catheter ablation (e.g., active endocarditis, uncorrected LA appendage thrombus), CHADS₂-VASc ≥2 requiring anticoagulation pre-procedure.
- •Catheter Ablation (Typical CTI-dependent flutter):
- Pre-op: TEE (transesophageal echo) + LA thrombus screen: ¥1,200 → $167 - Pre-op labs (coagulation panel, troponin, creatinine): ¥320 → $45 - Post-op overnight observation (1 night): ¥1,800 → $250
- •Hybrid Ablation (for atypical/complex flutter + structural heart disease):
Special/Complex Condition Management
- •Flutter with Severe LV Dysfunction (LVEF <35%): Requires amiodarone + ICD implantation (¥85,000–¥110,000 → $11,800–$15,300) before ablation consideration.
- •Post-Cardiac Surgery Flutter: Delay ablation ≥3 months; cost same as standard ablation but adds ¥2,200 ($310) for surgical scar mapping protocol.
- •Elderly (>80 years) with frailty: Rate control + rivaroxaban preferred; ablation only if highly symptomatic—costs unchanged but higher anesthesia monitoring fee (+¥1,500 → $210).
Quick Selection Guide
- •<65 years, no comorbidities, recurrent symptoms: First-line catheter ablation — highest long-term cost-efficiency; avoids lifelong drugs/monitoring.
- •≥75 years, CHADS₂-VASc ≥3, mild symptoms: Rivaroxaban + bisoprolol — lowest upfront cost ($110/month), avoids procedural risk.
- •LVEF <35% or prior SCD: Amiodarone + ICD, then ablation only after stabilization — prioritizes sudden death prevention.
- •Budget-constrained (<$500 total): Warfarin + diltiazem + basic labs — total setup cost ≈ $180, sustainable at <$35/month.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Atrial flutter Medical Vacation Packages
Curated transparent all-inclusive packages combining Atrial flutter treatment with China top medical destinations:
